MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Synergy Pharmaceuticals Company Profile (NASDAQ:SGYP)

Consensus Ratings for Synergy Pharmaceuticals (NASDAQ:SGYP) (?)
Ratings Breakdown: 1 Hold Rating(s), 5 Buy Rating(s)
Consensus Rating:Buy (Score: 2.83)
Consensus Price Target: $11.58 (240.69% upside)

Analysts' Ratings History for Synergy Pharmaceuticals (NASDAQ:SGYP)
Show:
DateFirmActionRatingPrice TargetActions
5/26/2016Roth CapitalReiterated RatingBuy$6.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/23/2016Rodman & RenshawReiterated RatingBuy$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/23/2016BTIG ResearchReiterated RatingBuy$11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/23/2016Canaccord GenuityReiterated RatingBuy$13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/16/2016Citigroup Inc.Lower Price TargetNeutral$7.00 -> $4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/1/2015HC WainwrightReiterated RatingBuy$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/18/2015Cantor FitzgeraldReiterated RatingBuy$8.50 -> $14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/12/2014Cowen and CompanyInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/14/2014AegisLower Price Target$26.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/28/2014 forward)
Earnings History for Synergy Pharmaceuticals (NASDAQ:SGYP)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/8/2016        
5/10/2016Q1($0.23)($0.51)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/9/2015Q315($0.28)($0.23)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/10/2015Q215($0.28)($0.34)$102.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/11/2015Q115($0.33)($0.28)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/16/2015($0.28)($0.32)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/10/2014($0.28)($0.24)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/11/2014($0.23)($0.28)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/13/2014Q114($0.23)($0.18)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/17/2014Q4 13($0.20)($0.22)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/12/2013Q3($0.17)($0.15)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/13/2012Q312($0.01)($0.15)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Synergy Pharmaceuticals (NASDAQ:SGYP)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.19)($0.19)($0.19)
Q2 20161($0.25)($0.25)($0.25)
Q3 20161($0.28)($0.28)($0.28)
Q4 20161($0.19)($0.19)($0.19)
(Data provided by Zacks Investment Research)
Dividend History for Synergy Pharmaceuticals (NASDAQ:SGYP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Synergy Pharmaceuticals (NASDAQ:SGYP)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
9/14/2015Bernard DenoyerSVPSell10,000$7.50$75,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/11/2015Alan JoslynDirectorSell13,754$7.22$99,303.88View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2014John P BrancaccioDirectorBuy3,500$4.12$14,420.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/27/2014Gary S JacobCEOBuy4,000$4.18$16,720.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/23/2014Bernard DenoyerSVPBuy2,500$3.89$9,725.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/23/2014Kunwar ShailubhaiInsiderBuy3,000$3.89$11,670.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/29/2013Gabriel CerroneDirectorBuy12,000$4.09$49,080.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/21/2013Bernard DenoyerSVPBuy7,500$4.78$35,850.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/14/2013Gabriel CerroneChairmanBuy8,000$4.42$35,360.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/24/2013Gabriel CerroneChairmanBuy5,500$4.66$25,630.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/5/2013Gabriel CerroneChairmanBuy5,000$6.15$30,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/4/2013Gabriel CerroneChairmanBuy13,090$6.04$79,063.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/30/2013Gabriel CerroneChairmanBuy26,000$5.98$155,480.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/14/2012Gabriel CerroneChairmanBuy87,820$3.61$317,030.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Synergy Pharmaceuticals (NASDAQ:SGYP)
DateHeadline
06/27/16 06:12 PMCramer: If the data's good, this stock could get a takeout bid -
06/27/16 10:31 AMHC Stocks Reports: Synergy Pharmaceuticals Inc (NASDAQ:SGYP), VIVUS, Inc. (NASDAQ:VVUS) - share market updates (press release)
06/24/16 06:28 PMHow Analysts Rated Synergy Pharmaceuticals Inc (NASDAQ:SGYP) Last Week? - Engelwood Daily
06/23/16 09:30 AMBillionaire John Paulson's Q1 Biotechs: AGN, SGYP -
06/23/16 08:59 AMLatest Analysts Tips Update: EXACT Sciences Corporation (NASDAQ:EXAS) , Synergy Pharmaceuticals, Inc ... - Street Updates
06/23/16 08:59 AMHC Stocks Highlights: Synergy Pharmaceuticals Inc (NASDAQ:SGYP), Hologic, Inc. (NASDAQ:HOLX) - share market updates (press release)
06/22/16 11:06 AMSynergy Pharmaceuticals, Inc. (NASDAQ:SGYP) Stock Momentum at Critical Inflection Point - CML News
06/21/16 10:40 AMSynergy Pharmaceuticals (SGYP) Stock: Buy The Dip! - aomarkets (registration) (blog)
06/21/16 10:40 AMWerner Enterprises Inc. (NASDAQ:WERN) Tumbled -10.86%: Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP), Old ... - KC Register
06/17/16 09:04 AMAnalyst's Notable Buzzers: Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) , Synergy Pharmaceuticals, Inc. (NASDAQ ... - Street Updates
06/16/16 06:37 PMStock to keep an eye on: Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) - News Oracle
06/16/16 06:37 PMComprehensive Report on: Interval Leisure Group, Inc. (NASDAQ:IILG), Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) - Beacon Chronicle
06/16/16 10:44 AMStocks Recommendation Update: Teva Pharmaceutical Industries Limited (NYSE:TEVA) , Synergy Pharmaceuticals ... - Street Updates
06/15/16 10:53 AMAnalyst Suggestions Roundup: Eli Lilly and Company (NYSE:LLY), Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) - Beacon Chronicle
06/14/16 06:04 PMPerformance Overview of the company: Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) - News Oracle
06/14/16 11:07 AMComprehensive Analysis of: DR Horton Inc. (NYSE:DHI), Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) - Beacon Chronicle
06/14/16 11:07 AMStock in Action: Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) - News Oracle
06/14/16 11:07 AMHC Stocks to watch for: Agios Pharmaceuticals Inc (NASDAQ:AGIO), Synergy Pharmaceuticals Inc (NASDAQ:SGYP) - share market updates (press release)
06/13/16 05:54 PMNotable Analysts Assessment of Stocks: CVS Health Corporation (NYSE:CVS) , Synergy Pharmaceuticals, Inc ... - Street Updates
06/10/16 06:42 PMAnalyst Earnings Report: Stone Energy Corp. (NYSE:SGY), Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) - Beacon Chronicle
06/10/16 09:24 AMAnalysts Watch-list Stocks: Hologic, Inc. (NASDAQ:HOLX) , Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) - Street Updates
06/09/16 06:53 PMEarnings Estimates Update: Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) - News Oracle
06/09/16 09:23 AMHC Stocks Reports: Express Scripts Holding Company (NASDAQ:ESRX), Synergy Pharmaceuticals Inc (NASDAQ:SGYP) - share market updates (press release)
06/09/16 09:23 AMNotable Earnings Analysis: Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP), Atlas Resource Partners, L.P. (NYSE:ARP) - Beacon Chronicle
06/09/16 05:00 AM[video]'Mad Money' Lightning Round: Take American Electric Power Over Calpine -
06/08/16 06:52 PMSynergy Pharmaceuticals Inc. (SGYP) Jumps 5.99% on June 07 - Equities.com
06/08/16 06:52 PMKeep an eye on Analyst Actions: Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) , Regulus Therapeutics Inc ... - Street Updates
06/08/16 06:26 PMCramer: The restaurant stock that totally dazzled me -
06/08/16 09:28 AMHC Stocks Summary: Synergy Pharmaceuticals Inc (NASDAQ:SGYP), AbbVie Inc (NYSE:ABBV) - share market updates (press release)
06/08/16 09:28 AMSYNERGY PHARMACEUTICALS INC. (NASDAQ:SGYP) Financial Condition Compared to S&P 500 - CML News
06/07/16 03:32 PMSYNERGY PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
06/06/16 06:29 PMStock to Focus on: Synergy Pharmaceuticals (SGYP) - News Oracle
06/03/16 07:02 PMBuy Sell or Hold? - Synergy Resources Corporation (NYSEMKT:SYRG), Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) - Beacon Chronicle
06/02/16 09:29 AMBiotech Movers Update: Abbott Laboratories (NYSE:ABT) , Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) - Is stories - Chicago TribuneBiotech Movers Update: Abbott Laboratories (NYSE:ABT) , Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP)Is storiesIn most recently trading session on 6/1/2016, Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) climbed +1.91% while traded on 2.3 million shares versus it's an average volume of 3.92 million shares. The company recorded the last trade with the price of $3 ...Noteworthy Analysts Suggestions: Abbott Laboratories (NYSE:ABT) , Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP)Street Updatesall 27 news articles »
06/01/16 06:59 PMWhat Analysts Have to Say About Synergy Pharmaceuticals Inc (NASDAQ:SGYP)? - The Point Review - CNA FinanceWhat Analysts Have to Say About Synergy Pharmaceuticals Inc (NASDAQ:SGYP)?The Point ReviewSynergy Pharmaceuticals Inc (NASDAQ:SGYP) has grabbed the attention from analysts, when it saw a value increase of 1.94 percent in the last trading session. A total of 4.32 million shares exchanged hands during the intra-day trade compared with its ...Earnings Reports To Watch: Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP)CWRU ObserverAnalyst Coverage: Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP)Risers & FallersStock Trending Up: Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP)The Postall 5 news articles »
06/01/16 04:04 PMSynergy Pharmaceuticals, Inc. :SGYP-US: Earnings Analysis: Q1, 2016 By the Numbers : June 1, 2016 -
06/01/16 09:19 AMNoteworthy Analysts Suggestions: Abbott Laboratories (NYSE:ABT) , Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) - Street Updates - Noteworthy Analysts Suggestions: Abbott Laboratories (NYSE:ABT) , Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP)Street UpdatesOn 5/31/2016, Abbott Laboratories (NYSE:ABT) ended trading session higher at $39.63 with +0.84%. The company traded a volume of 15.89 million shares as comparison to average volume of 9.02 million shares. During the 52 –week period, the stock's price ...and more »
05/31/16 09:47 AMStock's Earnings Activity: GlaxoSmithKline (GSK), Synergy Pharmaceuticals (SGYP) - Beacon Chronicle - Beacon ChronicleStock's Earnings Activity: GlaxoSmithKline (GSK), Synergy Pharmaceuticals (SGYP)Beacon ChronicleSynergy Pharmaceuticals Inc (NASDAQ:SGYP) currently has High Price Target of $15.00. The Low and Mean Price Targets are $4.00 and $9.90 respectively. These price targets are a consensus analysis of 5 brokers. When having a look at Recommendation ...and more »
05/31/16 09:47 AMPreview of Analysts Recommendation: Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) , Synergy Pharmaceuticals ... - Street Updates - Preview of Analysts Recommendation: Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) , Synergy Pharmaceuticals ...Street UpdatesSynergy Pharmaceuticals, Inc. (NASDAQ:SGYP) after beginning at $3.50, closed at $3.60 by building up +2.86% in recent trading session. Most recent session's volume of 2.04 million shares lower than its average volume of 3.91 million shares. The company ...and more »
05/31/16 12:42 AMNotable Moving HC Stocks: Synergy Pharmaceuticals Inc (NASDAQ:SGYP), Zoetis Inc (NYSE:ZTS) - share market updates (press release) - iStreetWireNotable Moving HC Stocks: Synergy Pharmaceuticals Inc (NASDAQ:SGYP), Zoetis Inc (NYSE:ZTS)share market updates (press release)Shares of Synergy Pharmaceuticals Inc (NASDAQ:SGYP) ended Friday session in green amid volatile trading. The shares closed up +0.10 points or 2.86% at $3.60 with 2.04 million shares getting traded. Post opening the session at $3.50, the shares hit an ...Yahoo! Inc. (NASDAQ:YHOO) & Synergy Pharmaceuticals (NASDAQ:SGYP) Worth Watching StocksWall Street 24Synergy Pharmaceuticals DE (NASDAQ:SGYP) Short Interest Decreased By 2.95%Franklin IndependentWhich way Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) insiders are headingiStreetWireall 4 news articles »
05/27/16 12:52 AMLatest Analysts Tips Update: Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) , Synergy Pharmaceuticals, Inc. (NASDAQ ... - Street Updates - Latest Analysts Tips Update: Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) , Synergy Pharmaceuticals, Inc. (NASDAQ ...Street UpdatesSynergy Pharmaceuticals, Inc. (NASDAQ:SGYP) after beginning at $3.63, closed at $3.55 by building up +0.28% in recent trading session. Most recent session's volume of 2.29 million shares lower than its average volume of 3.92 million shares. The company ...and more »
05/26/16 07:39 PMSynergy Pharma (SGYP) Presents Data Showing pH-Dependent Activity of Plecanatide Replicates That of Naturally - Join here. Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) today presented new in vitro data at Digestive Disease Week (DDW) showing plecanatide, an investigational compound being evaluated for chronic idiopathic constipation (CIC) and irritable bowel syndrome ...
05/26/16 01:55 AMAnalysts Weigh In: Positive Clinical Data Bodes Well For Synergy Pharmaceuticals Inc (SGYP) and Ariad ... - Smarter Analyst - Smarter AnalystAnalysts Weigh In: Positive Clinical Data Bodes Well For Synergy Pharmaceuticals Inc (SGYP) and Ariad ...Smarter AnalystSynergy Pharmaceuticals Inc (NASDAQ:SGYP) released positive data this week and Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) had an investor event, leading analysts to share updated insights. Synergy provided updated data on plecanatide in patients ...Extermination Of Constipation! Analysis Of Synergy PharmaceuticalsSeeking AlphaSynergy Pharmaceuticals (NASDAQ:SGYP) & AbbVie Inc (NYSE:ABBV) Healthcare Stocks Intraday AlertWall Street 24Synergy Pharma (SGYP) Announces Presentation of Additional Plecanatide Phase 3 Data in CICStreetInsider.comRisers & Fallers -NYSE Journal (press release) -share market updates (press release)all 25 news articles »
05/25/16 07:00 PMAnalysts Reviewing Stocks Update: Rock Creek Pharmaceuticals, Inc. (NASDAQ:RCPI) , Synergy Pharmaceuticals, Inc ... - Street Updates - Analysts Reviewing Stocks Update: Rock Creek Pharmaceuticals, Inc. (NASDAQ:RCPI) , Synergy Pharmaceuticals, Inc ...Street UpdatesIn the past trading session, Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) highlighted upward shift of +2.91% or +0.10 points to $3.54. The company traded a volume of 4.15 million shares over average volume of 3.9 million shares. Trailing twelve month ...and more »
05/25/16 01:01 AMSynergy Pharmaceuticals Inc (SGYP) Jumps 5.52% on May 23 - Equities.com - Synergy Pharmaceuticals Inc (SGYP) Jumps 5.52% on May 23Equities.comSynergy Pharmaceuticals Inc (SGYP) was among the biggest gainers on the Russell 2000 for Monday May 23 as the stock popped 5.52% to $3.44, representing a gain of $0.18 per share. Some 7.05 million shares traded hands on 23,443 trades, compared ...and more »
05/25/16 01:01 AMCompany Update (NASDAQ:SGYP): Synergy Pharmaceuticals Inc Presents New in Vitro Data Showing the Ph ... - Smarter Analyst - share market updates (press release)Company Update (NASDAQ:SGYP): Synergy Pharmaceuticals Inc Presents New in Vitro Data Showing the Ph ...Smarter AnalystSynergy Pharmaceuticals Inc (NASDAQ:SGYP) presented new in vitro data at Digestive Disease Week (DDW) showing plecanatide, an investigational compound being evaluated for chronic idiopathic constipation (CIC) and irritable bowel syndrome with ...Extermination Of Constipation! Analysis Of Synergy PharmaceuticalsSeeking AlphaSynergy Pharma (SGYP) Announces Presentation of Additional Plecanatide Phase 3 Data in CICStreetInsider.comSynergy Pharmaceuticals, Inc. (NASDAQ:SGYP) - Broker UpdateRisers & FallersInvestor Newswire -share market updates (press release) -NYSE Journal (press release)all 18 news articles »
05/24/16 07:23 PMTwo Healthcare stocks to Focus: Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) , BioDelivery Sciences International ... - Is stories - Two Healthcare stocks to Focus: Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) , BioDelivery Sciences International ...Is storiesSynergy Pharmaceuticals, Inc. (NASDAQ:SGYP) increased +5.52% to $3.44 while traded 7.09 million shares on 5/23/2016. The stock price negotiated for value between $3.25 to $3.58 in recent trading session. During the past 52 weeks, the stock's price ...and more »
05/24/16 07:23 PMAnalysts Ranking Previews: Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) , UnitedHealth Group Incorporated ... - Street Updates - Analysts Ranking Previews: Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) , UnitedHealth Group Incorporated ...Street UpdatesSynergy Pharmaceuticals, Inc. (NASDAQ:SGYP) accumulated +5.52%, closing at $3.44 after floating between $3.25 and $3.58. The company has market capitalization of $618.43M. It has twelve month low of $2.50 and twelve month high of $10.15. The recent ...and more »
05/24/16 07:23 PMExtermination Of Constipation! Analysis Of Synergy Pharmaceuticals - Seeking Alpha - share market updates (press release)Extermination Of Constipation! Analysis Of Synergy PharmaceuticalsSeeking AlphaSynergy Pharmaceuticals (NASDAQ:SGYP) is a small-cap research-stage biotech company listed on the Nasdaq. With a current price around $3 and a market cap around $600 million, SGYP will have a major catalyst in IBS-Constipation in Q3 2016.Company Update (NASDAQ:SGYP): Synergy Pharmaceuticals Inc Presents New in Vitro Data Showing the Ph ...Smarter AnalystSynergy Pharma (SGYP) Announces Presentation of Additional Plecanatide Phase 3 Data in CICStreetInsider.comSynergy Pharmaceuticals, Inc. (NASDAQ:SGYP) - Broker UpdateRisers & FallersInvestor Newswire -NYSE Journal (press release) -share market updates (press release)all 17 news articles »
05/23/16 07:06 PMSynergy Pharmaceuticals, Inc. (NASDAQ:SGYP) One-Year Price Target At $9.90 - Stocks Daily - Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) One-Year Price Target At $9.90Stocks DailyFirst Call has set a 52-week price target of $9.90 on Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) stock after completion of its survey. For the approaching quarter, EPS estimate is set at $-0.21 and for underway fiscal at $-1.01. This estimate for next ...and more »
About Synergy Pharmaceuticals

Synergy Pharmaceuticals logoSynergy Pharmaceuticals Inc. (Synergy) is a biopharmaceutical company focused on the development and commercialization of gastrointestinal (GI) therapies. The Company's GI platform includes two lead product candidates: plecanatide and dolcanatide. It is engaged in the discovery, research and development involving uroguanylin analogs for the treatment of functional GI disorders and inflammatory bowel disease. Plecanatide is the Company's uroguanylin analog being evaluated for use as a once-daily tablet for two functional GI disorders, chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C). Plecanatide is a 16-amino acid peptide that is structurally identical to uroguanylin with the exception of a single amino acid change. Dolcanatide is also its uroguanylin analog being explored for inflammatory bowel disease (IBD). Dolcanatide is designed to be an analog of uroguanylin with resistance to standard digestive breakdown by proteases in the intestine.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Other
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: SGYP
  • CUSIP: 87163930
Key Metrics:
  • Previous Close: $3.40
  • 50 Day Moving Average: $3.51
  • 200 Day Moving Average: $3.74
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $645.40M
  • Current Quarter EPS Consensus Estimate: $-1.01 EPS
Additional Links:
Synergy Pharmaceuticals (NASDAQ:SGYP) Chart for Tuesday, June, 28, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha